FORMULATION AND CHARACTERIZATION OF CYCLODEXTRIN BASED CURCUMIN LOADED NANOSPONGE

Authors

  • ANUP M. AKARTE Department of Pharmaceutics, K.V.P.S.’s Institute of Pharmaceutical Education, Boradi
  • PRAKASH H. PATIL Department of Pharmaceutics, K.V.P.S.’s Institute of Pharmaceutical Education, Boradi, India

DOI:

https://doi.org/10.22159/ijap.2022v14i1.42788

Keywords:

Nanosponge,Cyclodextrin, Cancer, curcumin and Nanosystem

Abstract

Objective: The aim of proposed work is to develop and screen cyclodextrin based Nanosponge loaded with poorly soluble anticancer drug and to optimize most suitable Nanosystem with increased solubility and dissolution rate.

Methods: Cyclodextrinnanosponge (CDNS) was prepared using pyromelliticdianhydride as a crosslinker for beta cyclodextrin monomer. Cyclodextrinnanosponge and curcumin were taken in 1:1 w/w proportion. The resultant curcumin loaded nanosponges were dried at 50 ±0.5°C for 24 h.

Results: the absorbance maxima for Curcumin was seen at 424.0 nm and for cyclodextrin was seen at 290.0 nm, The average melting point of pure drug is 1810C which is complies with Stander melting point of drug and the aspect ratio of the nanosponge was found 1.037. Zeta potential noticed for CUR-CD-NS were more negative contrasted with separate plain CUR (−20.1 ± 1.57) demonstrating solidness of the nanodispersion. Curcumin release from CUR-CDNS was upgraded to very nearly 10 folds toward the finish of 8 hour. Treatment with a combination of CUR-CDNS at 1:1 and 1:3 ratios resulted in an IC50 value was found 14.98 μg/ml.

Conclusion: In-vitro cytotoxicity study and combination index analysis showed the synergistic effect of CUR-CDNS against MCF-7 cells. The present study reveals that the combination of curcumin results in higher cytotoxicity against breast cancer cells.

Downloads

Download data is not yet available.

References

Priyadarsini KI. The chemistry of curcumin: from extraction to therapeutic agent. Molecules. 2014 Dec;19(12):20091-112.

Gupta SC, Sung B, Kim JH, Prasad S, Li S, Aggarwal BB. Multitargeting by turmeric, the golden spice: From kitchen to clinic. Molecular nutrition & food research. 2013 Sep;57(9):1510-28.

Unlu A, Nayir E, Kalenderoglu MD, Kirca O, Ozdogan M. Curcumin (Turmeric) and cancer. J buon. 2016 Sep 1;21(5):1050-60.

Lüer SC, Goette J, Troller R, Aebi C. Synthetic versus natural curcumin: bioequivalence in an in vitro oral mucositis model. BMC complementary and alternative medicine. 2014 Dec;14(1):1-7.

Singh S. From exotic spice to modern drug?. Cell. 2007 Sep 7;130(5):765-8.

Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: from ancient medicine to current clinical trials. Cellular and molecular life sciences. 2008 Jun;65(11):1631-52.

Qin F, Huang X, Zhang HM, Ren P. Pharmacokinetic comparison of puerarin after oral administration of Jiawei-Xiaoyao-San to healthy volunteers and patients with functional dyspepsia: influence of disease state. Journal of Pharmacy and Pharmacology. 2009 Jan;61(1):125-9.

Zhou H, S Beevers C, Huang S. The targets of curcumin. Current drug targets. 2011 Mar 1;12(3):332-47.

Prasad S, Gupta SC, Tyagi AK, Aggarwal BB. Curcumin, a component of golden spice: from bedside to bench and back. Biotechnology advances. 2014 Nov 1;32(6):1053-64.

Kocaadam B, Şanlier N. Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Critical reviews in food science and nutrition. 2017 Sep 2;57(13):2889-95.

Zhu L, Ding X, Zhang D, Ch Y, Wang J, Ndegwa E, Zhu G. Curcumin inhibits bovine herpesvirus type 1 entry into MDBK cells. Actavirologica. 2015 Sep 1;59(3):221-7.

Baglole KN, Boland PG, Wagner BD. Fluorescence enhancement of curcumin upon inclusion into parent and modified cyclodextrins. Journal of Photochemistry and Photobiology A: Chemistry. 2005 Jul 15;173(3):230-7.

Tønnesen HH. Solubility, chemical and photochemical stability of curcumin in surfactant solutions. Studies of curcumin and curcuminoids, XXVIII. Die Pharmazie. 2002 Dec 1;57(12):820-4.

Kim TH, Jiang HH, Youn YS, Park CW, Tak KK, Lee S, Kim H, Jon S, Chen X, Lee KC. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity. International journal of pharmaceutics. 2011 Jan 17;403(1-2):285-91.

Manju S, Sreenivasan K. Conjugation of curcumin onto hyaluronic acid enhances its aqueous solubility and stability. Journal of colloid and interface science. 2011 Jul 1;359(1):318-25.

Mohanty C, Sahoo SK. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials. 2010 Sep 1;31(25):6597-611.

Anitha A, Maya S, Deepa N, Chennazhi KP, Nair SV, Tamura H, Jayakumar R. Efficient water soluble O-carboxymethyl chitosan nanocarrier for the delivery of curcumin to cancer cells. Carbohydrate polymers. 2011 Jan 10;83(2):452-61.

Dhule SS, Penfornis P, Frazier T, Walker R, Feldman J, Tan G, He J, Alb A, John V, Pochampally R. Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma. Nanomedicine: nanotechnology, biology and medicine. 2012 May 1;8(4):440-51.

Byrne JD, Betancourt T, Brannon-Peppas L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Advanced drug delivery reviews. 2008 Dec 14;60(15):1615-26.

Yadav VR, Suresh S, Devi K, Yadav S. Effect of cyclodextrincomplexation of curcumin on its solubility and antiangiogenic and anti-inflammatory activity in rat colitis model. AapsPharmscitech. 2009 Sep;10(3):752-62.

Swaminathan S, Vavia PR, Trotta F, Torne S. Formulation of betacyclodextrin based nanosponges of itraconazole. Journal of inclusion phenomena and macrocyclic chemistry. 2007 Apr;57(1):89-94.

Cavalli R, Trotta F, Tumiatti W. Cyclodextrin-based nanosponges for drug delivery. Journal of inclusion phenomena and macrocyclic chemistry. 2006 Oct;56(1):209-13.

Torne SJ, Ansari KA, Vavia PR, Trotta F, Cavalli R. Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded nanosponges. Drug delivery. 2010 Aug 1;17(6):419-25.

Torne SJ, Ansari KA, Vavia PR, Trotta F, Cavalli R. Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded nanosponges. Drug delivery. 2010 Aug 1;17(6):419-25.

Shikha S, Priyanka C, Surendra KJ. Development And Performance Evaluation Of Tumor Targeting Potential Of Folate Spacer Functionalized Solid Lipid Nanoparticles, Asian Journal of Pharmaceuitcal& Clinical Research 2021 Sep 14(6)1-7.

Hirlekar RS, Kadam VJ. Design of buccal drug delivery system for a poorly soluble drug. Asian J Pharm Clin Res. 2009 Jul;2(3):49-53.

Bhanja S, Ellaiah P, Chandan M, Murthy KV, Bibhutibhusan P, Kumar PS. Design and in vitro evaluation of mucoadhesivebuccal tablets of perindopril prepared by sintering technique. Int J Pharm Tech Res. 2010;2(3):1810-23.

Swaminathan S, Vavia PR, Trotta F, Torne S. Formulation of betacyclodextrin based nanosponges of itraconazole. Journal of inclusion phenomena and macrocyclic chemistry. 2007 Apr;57(1):89-94.

Trotta, Francesco, Marco Zanetti, and Roberta Cavalli. "Cyclodextrin-based nanosponges as drug carriers." Beilstein journal of organic chemistry 8.1 (2012): 2091-2099.

Published

22-11-2021

How to Cite

AKARTE, A. M., & PATIL, P. H. (2021). FORMULATION AND CHARACTERIZATION OF CYCLODEXTRIN BASED CURCUMIN LOADED NANOSPONGE. International Journal of Applied Pharmaceutics, 14(1). https://doi.org/10.22159/ijap.2022v14i1.42788

Issue

Section

Original Article(s)